MUMBAI, India, July 25 -- Intellectual Property India has published a patent application (202517038078 A) filed by Virginia Commonwealth University; Illexcor Holdings, Llc; King Abdulaziz University; and Children's Hospital Of Philadelphia, Richmond, U.S.A., on April 21, for 'benzaldehyde compounds with direct polymer destabilizing effects to treat sickle cell disease.'
Inventor(s) include Safo, Martin; Zhang, Yan; Fleischman, Andrew; Light, David; El-Araby, Moustafa; Omar, Abdelsattar; and Abdulmalik, Osheiza.
The application for the patent was published on July 25, under issue no. 30/2025.
According to the abstract released by the Intellectual Property India: "Compounds and methods for preventing and/or treating one or more symptoms of sickle cell diseases (SCD) by administering at least one of the compounds are provided. The compounds are chemically modified to increase bioavailability and activity, e.g., so that the compounds prevent adhesion and sickling of red blood cells (RBCs)."
The patent application was internationally filed on Nov. 03, 2023, under International application No.PCT/US2023/036751.
Disclaimer: Curated by HT Syndication.
